A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01591512
(Decision was made by Sponsor to stop the trial.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Small cell lung cancer patients undergoing treatment.
Age ≥ 18
Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
Able to understand and willing to provide Informed Consent
No diagnosis of SCLC
Not scheduled to undergo treatment for the diagnosis of SCLC